Emergent BioSolutions (EBS) - Stock price history

Stock price history of Emergent BioSolutions from 2006 to 2025

Annual Stock Price Performance

Year	Performance
2025	20.93%
2024	269.11%
2023	-80.03%
2022	-75.38%
2021	-53.31%
2020	65.93%
2019	-6.50%
2018	23.58%
2017	39.84%
2016	-13.78%
2015	48.74%
2014	13.36%
2013	36.04%
2012	-5.65%
2011	-29.18%
2010	69.88%
2009	-45.83%
2008	412.97%
2007	-55.22%
2006	-4.62%

Stock price for similar companies or competitors

Company	Stock price	Change 1d%	Country
Merck MRK	NZ$175.56	0.40%	🇺🇸 USA
SIGA Technologies SIGA	NZ$10.89	-0.63%	🇺🇸 USA
GlaxoSmithKline GSK	NZ$84.42	0.66%	🇬🇧 UK
Celldex Therapeutics CLDX	NZ$44.46	1.23%	🇺🇸 USA
Pfizer PFE	NZ$43.75	0.60%	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	NZ$52.71	0.10%	🇮🇱 Israel
Soligenix SNGX	NZ$2.40	12.20%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Stock price history for Emergent BioSolutions (EBS)